Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Marc Dunoyer Insider Profile
4 Followers
Marc Dunoyer, Chief Financial Officer at AstraZeneca, holds 353.98K shares in AstraZeneca (Ticker: GB:AZN), holds 0.00 shares in GlaxoSmithKline (Ticker: GB:GSK).
Marc Dunoyer AstraZeneca (AZN)Chief Financial Officer
AstraZeneca (AZN)
Chief Financial Officer
Ranked #32,513 out of 98,624 Corporate Insiders
Profitable Transactions
1 out of 3 Profitable Transactions
Average Return
+12.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Marc Dunoyer holds in companies
Most Profitable Insider Trade
The most profitable trade made by Marc Dunoyer
Marc Dunoyer's Trading History
AstraZeneca
Jul 21, 2021
Chief Financial Officer
Uninformative Buy
―
£42.70M
GlaxoSmithKline
Mar 19, 2013
Senior Officer
Informative Sell
626.96K
£0.00
List of latest transactions for each holding click on a transaction to see Marc Dunoyer's performance on stock
You May Also Like
Marc Dunoyer insider profile FAQ
What is the percentage of profitable transactions made by Marc Dunoyer?
The percentage of profitable transactions made by Marc Dunoyer is 33%.
What is the average return per transaction made by Marc Dunoyer?
The average return per transaction made by Marc Dunoyer is 12.90%.
What stocks does Marc Dunoyer hold?
Marc Dunoyer holds: GB:AZN, GB:GSK stocks.
What was Marc Dunoyer’s latest transaction?
Marc Dunoyer latest transaction was an Uninformative Buy of ―.
What was Marc Dunoyer's most profitable transaction?
Marc Dunoyer’s most profitable transaction was an Informative Buy of GB:AZN stock on May 8, 2019. The return on the trade was 51.10%.
What is Marc Dunoyer's role in AstraZeneca?
Marc Dunoyer's role in AstraZeneca is Chief Financial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.